Intellia Therapeutics
+$0.72 (+1.14%) As of 1:42 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NTLA and other ETFs, options, and stocks.
About NTLA
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases.
CEO
John M. Leonard
Employees
485
Headquarters
Cambridge, Massachusetts
Founded
2014
NTLA Key Statistics
Market cap
4.85B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.68M
High today
$64.89
Low today
$62.65
Open price
$62.77
Volume
172.16K
52 Week high
$180.59
52 Week low
$37.08
NTLA News
Analyst ratings
88%
of 24 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
NTLA Earnings
-$1.96
-$1.31
-$0.65
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market